Global expansion Microbiologics has recently expanded its network with acquisitions and facility growth, notably the SensID GmbH acquisition in 2025 and San Diego biosafety lab expansions in 2023, signaling ongoing international market penetration and capacity growth that can be leveraged to sell complementary biological controls, assay services, and diagnostics partnerships.

Broad tech stack With a diversified technology footprint including Salesforce, Oracle Cloud, SAP Concur, Microsoft 365, and multiple cloud platforms, there are ample cross-sell or integration opportunities for digital procurement, CRM-driven sales enablement, and data analytics services to streamline customers' lab operations.

Strategic collaborations Recent partnerships and collaborations with distributors and industry events, such as NCIMB Ltd and CAP Today webinars, indicate a strong channel strategy and thought leadership avenue to expand reach into new labs and life science facilities that require validated microbiology controls and consulting.

Product and service scope Microbiologics offers biological control materials, assay services, and consulting across microbiology, molecular diagnostics, and virology, creating multiple entry points for upsell to existing healthcare and life science customers, including automated workflows and quality control solutions for AST and GN‑AST processes.

Financial and scale With revenue in the 100M to 250M range and a headcount of 201–500, Microbiologics sits between mid and larger players, presenting opportunities to target mid‑sized labs and regional distributors for scalable, repeatable purchasing programs and long‑term service contracts.